
Anlon Healthcare IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Tue Aug 26 2025

The Anlon Healthcare IPO GMP is ₹5 as of 26th August 2025. It is a bookbuilding IPO of ₹121.03 crores. This is an entirely fresh issue of 1.33 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 3rd September 2025. The face value of Anlon Healthcare shares stands at ₹10 per share, and the IPO price band is set at ₹86.00 to ₹91.00 per share. Retail investors can bid for a minimum of one lot of 164 shares worth ₹14,924.
Anlon Healthcare IPO GMP Grey Market Premium
As of 26th August 2025, the Anlon Healthcare IPO GMP stands at ₹5 per share. Thus, the estimated listing price would be ₹96. This indicates that the estimated listing gain in this IPO could be 5.49%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Anlon Healthcare IPO GMP updates.
GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
26-08-2025 | ₹91.00 | ₹5.00 | ₹96.00 | 5.49% |
25-08-2025 | ₹91.00 | ₹5.00 | ₹96.00 | 5.49% |
24-08-2025 | ₹91.00 | ₹0.00 | ₹91.00 | 0.00% |
23-08-2025 | ₹91.00 | ₹0.00 | ₹91.00 | 0.00% |
22-08-2025 | ₹91.00 | ₹0.00 | ₹91.00 | 0.00% |
21-08-2025 | ₹91.00 | ₹0.00 | ₹91.00 | 0.00% |
Anlon Healthcare IPO Details
IPO Open Date | 26th August 2025 |
IPO Close Date | 29th August 2025 |
IPO Allotment Date | 1st September 2025 |
Refund Initiation | 2nd September 2025 |
Issue Size | 1,33,00,000 shares(aggregating up to ₹121.03 Cr) |
Face Value | ₹10 per share |
Lot Size | 164 shares |
Issue Price Band | ₹86.00 to ₹91.00 per share |
Issue Type | Bookbuilding IPO |
Listing At | BSE & SME |
Listing Date | 3rd September 2025 |
Explanation
Anlon Healthcare IPO: Anlon Healthcare Limited has declared that the issue price band is set between ₹86.00 and ₹91.00 per share. With this IPO, the company allows retail investors to bid for at least one lot of 164 shares worth ₹14,924. The face value of Anlon Healthcare Limited shares is ₹10 per share. The shares of Anlon Healthcare Limited will be listed on BSE and NSE on its tentative listing day, 3rd September 2025. Scroll down to check GMP updates and Anlon Healthcare IPO reviews.
Objectives of the Anlon Healthcare IPO
The primary aim of the Anlon Healthcare IPO is to raise ₹121.03 crores. On the other hand, Anlon Healthcare has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Anlon Healthcare IPO.
- To meet the general corporate purpose.
- To fund the working capital requirement.
- To fund capital requirements for the expansion.
- To prepay certain borrowings of the company.
Anlon Healthcare IPO Registrar
Kfin Technologies Limited is the registrar of the Anlon Healthcare IPO, responsible for managing the IPO allotment procedure and refund initiation. For any queries regarding the Anlon Healthcare allotment and refund, you can contact Kfin Technologies Private Limited at
reachus@kfintech.com, 04067162222, 04079611000.
Anlon Healthcare IPO Review

The Anlon Healthcare IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Anlon Healthcare Limited’s revenue increased by 81% from ₹66.69 crores in March 2024 to ₹120.46 crores in March 2025. Moreover, the company’s PAT rose by 112% from ₹9.66 crores to ₹20.52 crores. Investors can analyse other relevant factors and make a decision accordingly.
Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Anlon Healthcare IPO or not.
Anlon Healthcare Limited Technicals
Key Indicators | Value |
PE Ratio (Price-to-Earnings) | 17.67 |
EPS (Earnings Per Share) | 5.15 |
RoNW | 25.51 |
ROCE | 21.93 |
ROE | 40.45 |
EBITDA Margin | 26.88 |
Price to Book Value | 4.51 |
Market Capitalisation | ₹483.68 Cr |
The PE ratio of Anlon Healthcare Limited shares is 17.67, and its Earnings Per Share (EPS) stands at ₹5.15. Thus, the Anlon Healthcare IPO can potentially deliver gains on its tentative listing date, 3rd September 2025.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Anlon Healthcare Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.
Anlon Healthcare Limited IPO Peer Comparison
Company Name | EPS | P/E Ratio | RoNW | Face value | Revenue |
Anlon Healthcare Industries Limited | 6.38 | 17.67 | 25.51 | ₹10 | 66.58 |
Kronox Lab Sciences | 6.91 | 26.18 | 28.26 | ₹10 | 91.44 |
Acutaas Chemicals | 19.81 | 58.47 | 12.15 | ₹5 | 725.00 |
Supriya Lifeciences | 23.35 | 29.27 | 18.86 | ₹2 | 581.00 |
Also Read : Mangal Electrical IPO GMP: Day 3 IPO Live Updates
FAQs on Anlon Healthcare IPO
What is the Anlon Healthcare IPO GMP?
Ans. Currently, on 26th August 2025, the Anlon Healthcare IPO GMP (Grey Market Premium) stands at ₹43. This indicates that the estimated listing price could be ₹123 per share.
What is the issue price of the Anlon Healthcare IPO?
Ans. The Anlon Healthcare IPO price is set at ₹86.00 to 91.00 per share. Retail investors can apply for a minimum of 1 lot consisting of 164 shares worth ₹14,925. Moreover, HNIs are required to bid for a minimum of 14 lots (2,296 shares) worth ₹2,08,936.
Who is the registrar of the Anlon Healthcare IPO?
Ans. Kfin Technologies Private Limited is the registrar of the Anlon Healthcare IPO, responsible for managing the IPO allotment procedure and refund initiation. For any queries regarding the Anlon Healthcare allotment and refund, you can contact Kfin Technologies
Private limited at reachus@kfintech.com, 04067162222, 04079611000.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Anlon Healthcare IPO, download the Anlon Healthcare IPO RHP and Anlon Healthcare IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Explore Other News Articles
Oval Projects Engineering IPO GMP & Review: Apply or Avoid?
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Abril Paper Tech IPO GMP & Review: Apply or Avoid?
Snehaa Organics IPO GMP & Review: Apply or Avoid?
Anondita Medicare IPO Subscription Day 2
Related Posts
Suryavanshi Spinning Mills Q1 Results FY26: Q1 PAT Rises 82.43% to -₹0.21 Crore; Revenue up 4,595.83% YoY
Mohite Industries Q1 Results FY26: Q1 PAT Falls 148.22% to -₹1.01 Crore; Revenue Down 1.01% YoY
Vikran Engineering IPO GMP: Day 1 IPO Live Updates
Stock Market Today: Sensex Drops 550.63 Points Down; Nifty Scales 24,799.85 | Check More Updates
